Clinical Trial Update: JAK/STAT Inhibition in CNS Kohlmeier-Degos Disease [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating a JAK/STAT pathway inhibitor in Kohlmeier-Degos disease with neurologic involvement. The study has completed and results hav…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degos Disease
• Kohlmeier-degos Disease with Neurologic Involvement

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Kohlmeier Degos Disease With Neurologic Involvement, Kohlmeier-Degos Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2026-02-03